Today I’m traveling to Washington DC in order to attend the 13th Annual Wenger Award Ceremony. The celebration is hosted by WomenHeart: the National Coalition for Women with Heart Disease. Honorees will include The Honorable Debbie A. Stabenow, U.S. Senator, State of Michigan; Carolyn M. Clancy, M.D., Director, Agency for Healthcare Research and Quality (AHRQ); Abbott Vascular: and Rita Redberg, M.D., M.Sc, the Editor in Chief of the Archives of Internal Medicine.
For me, the event promises to be very exciting; after all, I will have the opportunity to communicate with some of the most important leaders in the national initiative to understand and thus prevent cardiovascular disease in women. But the event means much more than that. It represents the great strides that are being taken to finally identify and distinguish important aspects of cardiovascular disease between the sexes.
Until about 10 years ago cardiovascular disease was felt to be a man’s problem. We have grown to understand that women too are plagued by this Leviathan of ailments. In fact, cardiovascular disease is the leading cause of death in women, outstripping even breast cancer by 11-fold. Women have differences in their cardiovascular risk factors, their symptoms, and their response to treatments, both invasive and non-invasive. Physicians must learn to evaluate and treat women differently from the way they do men.
The American Society for Preventive Cardiology (ASPC) is also doing its part to “spread the word”. On July 12 and 13 at the spectacular Boca Raton Resort, the ASPC will host its Second Annual Women’s CVD Prevention Conference. Last year was a great success and this year promises to be even better. Sponsored by Boca Raton Regional Hospital and endorsed by such organizations as WomenHeart and Go Red for Women, doctors and physician-extenders will be taught by the best of the best. Professors from Harvard, John’s Hopkins, Duke, the Mayo Clinic, UCSD, Emory, and other prestigious universities will come together in Boca Raton in order to teach clinicians practical aspects of managing their women patients.
The conference, which I will be chairing, is an unprecedented venue for clinicians to elevate their management of cardiovascular disease and its risk factors in women. I would highly encourage practitioners from around the country to attend. To learn more about the program, and sign up for attendance please visit aspconline.org. I promise you will not be disappointed.
Please read more about preventive cardiology at www.preventivecardiologyinc.com.